Skip to main content
. 2024 Mar 14;15:1380541. doi: 10.3389/fneur.2024.1380541

Table 1.

Demographic data of patients with positive serum fixed CBA anti-MOG results who were included in this assessment.

All positive anti-MOG results N = 85 Low-positive anti-MOG results (Titer < 1:100) N = 47 Clear-positive anti-MOG results (Titer ≥ 100) N = 38 p-value*
Median age at time of testing, years (range) 16.1 (0.2–77.1) 17.2 (1.1–77.1) 14.6 (0.2–77.0) 0.26
Pediatric (%) 54 (64) 28 (60) 26 (68) 0.50
Female (%) 41 (48) 21 (45) 20 (53) 0.52

*p-value refers to comparison of difference between low-positive and clear-positive anti-MOG results.

CBA, cell-based assay; MOG, myelin oligodendrocyte glycoprotein.